SAO · BLAU3.SA
Blau Farmacêutica S.A.
R$9.15-R$0.20 (-2.14%)
Blau Farmacêutica S.A.’s quoted price sits in the lower half of its reported 52-week range, 36.9% below the high.
Loading market information…
SAO · DASA3.SA · BRL
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:07 PM UTC. Cached market data; not a live quote.
One-year closing-price history · BRL. Historical prices are not a forecast.
Diagnósticos da América S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Diagnósticos da América S.A.’s forward annual dividend is R$0.10 per share, paid annual. The forward yield is 3.22% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Diagnósticos da América S.A.’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of R$0.02. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Diagnósticos da América S.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. The company operates through Hospitals and Oncology; Diagnostics - National Operations; and Diagnostics - International Operations segments. It also offers medical, property and vehicle rental, consultancy, and franchise contracting services. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in São Paulo, Brazil.
Latest available per-share figures in BRL. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:24 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 13, 2025 | -R$0.09+35.71% vs estimate | R$3.83B-3.76% vs estimate |
|---|
| Q4 2024 | Mar 27, 2025 | -R$0.30-67.48% vs estimate | R$3.67B-2.02% vs estimate |
|---|
| Q3 2024 | Nov 14, 2024 | -R$0.11-1,000.0% vs estimate | R$3.97B+1.4% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
R$9.15-R$0.20 (-2.14%)
Blau Farmacêutica S.A.’s quoted price sits in the lower half of its reported 52-week range, 36.9% below the high.
R$2.50-R$0.06 (-2.34%)
Empreendimentos Pague Menos S.A.’s quoted price sits in the lower half of its reported 52-week range, 67.19% below the high.
R$10.11-R$0.18 (-1.75%)
Dimed S.A. Distribuidora de Medicamentos’s quoted price sits in the lower half of its reported 52-week range, 38.99% below the high.
R$0.76+R$0.05 (+7.04%)
Oncoclínicas do Brasil Serviços Médicos S.A.’s quoted price sits in the lower half of its reported 52-week range, 75.24% below the high.
R$6.60-R$0.00 (0.0%)
Profarma Distribuidora de Produtos Farmacêuticos S.A.’s quoted price sits in the lower half of its reported 52-week range, 31.96% below the high.
R$5.37+R$0.02 (+0.37%)
Biomm S.A.’s quoted price sits in the lower half of its reported 52-week range, 44.92% below the high.
R$2.49+R$0.03 (+1.22%)
Allianca Saude e Participacoes S.A.’s quoted price sits in the lower half of its reported 52-week range, 59.77% below the high.
R$1.34+R$0.04 (+3.08%)
Qualicorp Consultoria e Corretora de Seguros S.A.’s quoted price sits in the lower half of its reported 52-week range, 51.28% below the high.
